Diagnosis of AD relies on multidisciplinary approaches, requiring in particular expensive imaging procedures and invasive collection of cerebrospinal fluid (CSF) for biomarkers analysis (4): Aβ (in particular Aβ42), tau, and phospho-tau (p-tau) proteins. Here, MAPT is linked to Alzheimer disease.